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Abstract: The interest in the biological properties of grapevine polyphenols (PPs) in neuroprotection 
is continuously growing in the hope of finding translational applications. However, there are several 
concerns about the specificity of action of these molecules that appear to act non-specifically on the 
permeability of cellular membranes. Naturally occurring neuronal death (NOND) during cerebellar 
maturation is a well characterized postnatal event that is very useful to investigate the death and 
rescue of neurons. We here aimed to establish a baseline comparative study of the potential to 
counteract NOND of certain grapevine PPs of interest for the oenology. To do so, we tested ex vivo 
the neuroprotective activity of peonidin- and malvidin-3-O-glucosides, resveratrol, polydatin, 
quercetin-3-O-glucoside, (+)-taxifolin, and (+)-catechin. The addition of these molecules (50 μM) to 
organotypic cultures of mouse cerebellum explanted at postnatal day 7, when NOND reaches a 
physiological peak, resulted in statistically significant (two-tailed Mann–Whitney test—p < 0.001) 
reductions of the density of dead cells (propidium iodide+ cells/mm2) except for malvidin-3-O-
glucoside. The stilbenes were less effective in reducing cell death (to 51–60%) in comparison to 
flavanols, (+)-taxifolin and quercetin 3-O-glucoside (to 69–72%). Thus, molecules with a -OH group 
in ortho position (taxifolin, quercetin 3-O-glucoside, (+)-catechin, and peonidin 3-O-glucoside) have 
a higher capability to limit death of cerebellar neurons. As NOND is apoptotic, we speculate that 
PPs act by inhibiting executioner caspase 3. 
Keywords: resveratrol; polydatin; peonidin 3-O-glucoside; malvidin 3-O-glucoside; quercetin 3-O-
glucoside; (+)-catechin; (+)-taxifolin; apoptosis; neuronal death; cerebellum 
 
1. Introduction 
We know a great deal about the chemistry of grapevine polyphenols (PPs) because they are 
widely studied for their implications in wine production and biological role in the grapevine response 
to biotic and abiotic stress. Notably, there is also a huge body of preclinical evidence on the numerous 
cellular mechanisms targeted by these substances (resveratrol, in particular) in relation to several 
pathological conditions including neurological diseases [1,2], but results are often heterogeneous or 
inconsistent. There may be several reasons for the heterogeneity and lack of consistency of in vitro 
and/or animal studies on (grapevine) PPs. First, these studies have come under heavy criticism 
because they have used artificially high doses. However, an additional and even more important 
concern is that they are unreliable because many of the effects of polyhydroxylated natural 
phytochemicals, such as resveratrol and epigallocatechin gallate, were reported to be due to aspecific 
cell membrane perturbations, rather than specific protein binding [3]. Therefore, doubts arose that 
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these molecules are pan-assay interference compounds that affect the accuracy of many assays [4,5]. 
Other more particular reasons for the divergences in the outcomes of animal experiments may be the 
following. First, researchers at times have tested the effects of pure molecules but, other times, those 
of crude plant extracts, with a substantial heterogeneity of results that have been difficult to compare 
because very often the concentrations of the individual PPs in extracts were unknown. Second, certain 
experiments used the PPs obtained from different grapevine organs, which contain very 
heterogeneous levels of these molecules, as it occurs, for example, for leaves compared to other 
organs of the grapevine [6,7]. Third, starting from different sources of PPs (wines) diverse extraction 
methods were reported to display very different degrees of efficiency, and to produce chemically 
heterogeneous extracts when the effects of three critical variables (sample volume, volume of each 
eluent, and solvent percentage in eluent) were evaluated for non-polymeric phenol and tannin 
recoveries from wine [8]. This is a very important issue to be considered when purifying PPs-
containing samples for studying biological or health-related investigations as polymeric phenols are 
not absorbed by mammalian cells but are able to bind to and affect nearly any enzyme or receptor, 
producing irrelevant results [3]. Fourth, further complexity arose from the different results that 
researchers have reported in vivo or in vitro [6]. For instance, PPs displayed a very promising in vitro 
antioxidant capacity leading to the misconception that their cellular protection was mainly due to 
direct antioxidant scavenging [9]. Rather, studies with cellular and animal models demystified this 
concept, and now we know that the mode of action of PPs goes far beyond their antioxidant potential 
but also that their brain bioavailability is very limited [10]. Last, investigators have often focused their 
attention onto one single PP or group of chemically related molecules, thus making it quite difficult 
a sound comparison of the neuroprotective potential of individual PPs. 
PPs of potential biomedical interest belong to several chemical families among which the most 
widely studied are stilbenes, anthocyanins, flavonols, and flavan-3-ols. 
Stilbenes are a group of PPs that raised much interest in viticulture, as they are involved in the 
grapevine response to biotic stress, but also and even most in biology and health science. In 
preclinical neuroscience studies, resveratrol, the most widely investigated stilbene and the prototype 
of grapevine PPs studied so far, has been reported to have neuroprotective, antioxidant and anti-
inflammatory, properties. Much of its purported benefits have been related to its ability to activate a 
family of proteins called sirtuins [11], but there is considerable conflict in the literature as regarding 
the true neuroprotective potential of these proteins [12]. The literature concerning the activation of 
sirtuin 1 (sirt1) by resveratrol is similarly controversial: the first studies indicated resveratrol as an 
activator of sirt1 [13], but subsequent experiments revealed that the stilbene-dependent activation of 
sirt1 was a technical artifact [14–16]. Resveratrol has also been touted as a treatment to slow 
physiological aging and age-related diseases including dementia and Alzheimer’s disease (AD) to 
eventually extend healthy lifespan. However, although resveratrol significantly extended lifespan in 
yeast, worms, and fruit flies [13,17], most studies reported no effect in mammals [18,19] and, very 
recently, the molecule was reported to exhibit biphasic dose-dependent effects acting as an 
antioxidant or as a pro-oxidant at low and high concentrations, respectively [20]. 
In the present study, we tested the death-combating effects of trans-resveratrol and polydatin, 
the glucose derivative of resveratrol, also termed piceid. Polydatin is generally predominant in white 
wines, whereas in red wines Z- and E-resveratrol are both quantitatively important [21]. Resveratrol 
is accumulated also in grapevine leaves, where its concentration was found to be up to ten times 
higher in organically-managed vines, respect to conventionally grown vines, and in both cases 
extracts were effective in reducing the lipid and protein damages induced by hydrogen peroxide in 
the rat brain [22]. In addition, two very recent studies have shown that polydatin protected SH-SY5Y 
neurons after rotenone treatment to model Parkinson’s disease [23] or from oxidative stress [24]. 
The efficacy of anthocyanins as potential therapeutic agents to combat neurodegeneration was 
tentatively linked to the different levels of hydroxylation in the B ring of the flavilyum ion, as it was 
suggested that the anthocyanins with a catechol moiety in their B ring could be more effective in 
neuroprotection compared to those devoid of catechol [25]. Specifically, the non-catechol 
pelargonidin 3-O-glucoside protected neurons from the oxidative stress elicited by glutamate but was 
Molecules 2020, 25, 2925 3 of 18 
 
ineffective against nitric oxide-induced apoptosis [26], whereas the catechol-structure cyanidin 3-O-
glucoside (di-hydroxylated) was neuroprotective under both experimental conditions [27]. In 
addition, a combination of several anthocyanins was found to be protective against H2O2-induced 
oxidative stress in cultured human neuroblastoma cells [28] or C6 glial cells [29]. We here tested 
peonidin 3-O-glucoside (Pn-3OG) as the main representative of the anthocyanins in a few but locally 
very important varieties of Vitis vinifera [30] and malvidin 3-O-glucoside (Mv-3OG), quantitatively, 
without any doubt, the most important anthocyanin found in grape berries, musts and wines [31]. 
Another reason why we investigated the neuroprotective effect of Mv-3OG is that in vitro studies on 
SH-SY5Y human neuroblastoma cells [32] or C6 glial cells [29] have demonstrated protection against 
oxidative stress. However, the situation in vivo was quite different as the molecule overpassed the 
blood–brain barrier (BBB) in rats, but had no detectable effects in reducing the generation of the 
amyloid β (Aβ) peptides that are critical for the onset and progression of AD [33]. 
Flavonols are important PPs conferring to vegetal tissue high or very high antioxidant 
properties. They were protective in vitro against reactive oxygen species (ROS) challenge of SH-SY5Y 
neuroblastoma cells [32] and quercetin 3-O-glucuronide was capable to interfere with the generation 
of Aβ through the modulation of several different independent cellular mechanisms [33]. Moreover, 
quercetin 3-O-glucuronide significantly improved basal synaptic transmission in a hippocampal slice 
ex vivo preparation to model AD [33]. 
Based on these observations and on the fact that quercetin glycosides (glucoside + glucuronide) 
are, quantitatively, the most important flavonol in grape extracts and wines, we tested quercetin 3-
O-glucoside as representative of the flavonols. 
Monomeric grapevine flavan-3-ols include (+)-catechin with its diasteroisomer, (−)-epicatechin, 
and gallocatechin with its diasteroisomer epigallocatechin, differing for the level of hydroxylation in 
the B ring [34]. Monomeric flavan-3-ols were neuroprotective in a rat model of AD [35]. Therefore, 
we here have investigated (+)-catechin for its potential in limiting neuronal cell death. 
Although at present not much is known about grapevine flavanonols, (+)-taxifolin 
(dihydroquercetin) has been very recently found to protect neurons against ischemic injury in vitro 
via the inhibition of excessive ROS production and of the irreversible increase of cytosolic Ca2+ 
concentration in GABAergic hippocampal neurons subjected to oxygen and glucose deprivation 
(OGD) to mimic ischemia [36]. 
Despite the notable amount of preclinical data on these four families of PPs, human clinical 
studies are occasional and thus the true translational potential of grapevine and other PPs in clinical 
neurology remains almost fully unexplored. For example, AD patients have lower cortical levels of 
sirt1, which indirectly correlated with greater levels of Aβ plaques and tau protein tangles [11,37]. 
Conversely, subjects with mild cognitive impairment (MCI) did not show reduced cortical sirt1 levels 
[11], indirectly suggesting that preventing sirt1 decreases at early stages of dementia may help delay 
or prevent the progression to AD. However, there is no evidence that treating humans with 
resveratrol can increase sirt1 in the brain [20]. In addition, clinical trials have up to now failed to show 
ameliorations of the clinical conditions in neurological patients under a resveratrol regimen [38,39] 
or epigallocathecin gallate [40] and a recent systematic review did not find sufficient evidence to 
confirm that PPs have beneficial effects against AD and other neurodegenerative conditions [41]. 
In the attempt to shed more light onto the neuroprotective potential of some grapevine PPs of 
shared interest for the viticulturists and the neuroscientists we have devised an initial study aiming 
to clarify the intervention of these molecules in protecting neurons from naturally occurring neuronal 
death (NOND) during the course of cerebellar maturation. Given the aforementioned limitations of 
much of the preclinical studies on the subject and the difficulty in translating these studies into the 
clinics, we have limited our work to a simplified and restricted experimental paradigm that: i. 
Exploits a well-known and widely characterized model of NOND [42]; ii. Compares the effects of 
commercially available purified PPs to overcome the problems that are inherent to the different 
extraction procedures; iii. Uses a slice culture approach to better mimic the in vivo situation; and iv. 
Uses a standardized concentration of PPs (50 μM) that is well below the highest doses (200 μM and 
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above) employed in a wide number of studies in vitro [43]. We also discuss our results in relation to 
the information in the literature obtained from in vivo, ex vivo, and in vitro approaches. 
2. Results 
2.1. Effect of Ethanolic Media Onto Naturally Occurring Neuronal Death (NOND) in Postnatal Cerebellum 
During postnatal cerebellar development there is a well-characterized period of apoptotic cell 
death [42] currently referred to as naturally occurring neuronal death (NOND). NOND primarily 
affects the developing granule cells and is a massive phenomenon, so that it can be easily followed 
in slice cultures and is amenable to quantitative analysis (Figure 1A). As PPs are soluble in ethanolic 
solutions and ethanol itself induces death in neurons, we have devised a series of experiments in 
which cerebellar slices were maintained in vitro in the presence of progressively increasing 
concentrations of ethanol to assess the outcome on cerebellar NOND (Figure 1). 
 
Figure 1. Limitation of naturally occurring neuronal death (NOND) in the postnatal cerebellum after 
ex vivo treatment with polyphenols (PPs). The nuclei of dead cells are strongly fluorescent in red after 
incubation with propidium iodide (PI). PI is a fluorescent intercalating DNA stain that is not 
membrane permeable. Thus, it only enters the nucleus of damaged cells and can therefore be used to 
differentiate dead cells (apoptotic, necrotic, etc.) from healthy cells based on membrane integrity. As 
170 mM ethanol in which PPs are dissolved does not significantly alter cell death, it can be used as a 
baseline control (CTR) for the experiments to ascertain the effects of PPs onto NOND. The three panels 
are representative images of the experiments carried out with ethanol 170 mM (A) and with 
individual PPs, resveratrol 50 μM (B) and (+)-catechin 50 μM (C). 
The graphs in Figure 2A–B show the effects of 1:100, 1:50, and 1:25 ethanol in medium 
(corresponding to 170, 340, and 680 mM, respectively) on the density of dead cells after PI staining (# 
cells stained with PI/mm2). Notably, the density of dead cells (mean ± 95% CI) raised from 17.56 ± 
17.73 in plain medium, to 23.47 ± 8.76 (170 mM ethanol), 34.24 ± 2.30 (340 mM ethanol), and 78.11 ± 
22.41 (680 mM ethanol). 
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Figure 2. Descriptive exploratory statistics (A) and inferential statistics (B) of the effects of different 
ethanol concentrations in culture medium onto cerebellar naturally occurring neuronal death 
(NOND). Dead cells were stained with propidium iodide and results are expressed as means of dead 
cells/area. Two-tailed Kruskal–Wallis test and Dunn’s multiple comparison test (plain medium vs 
ethanolic media) were applied, as data did not pass the D’Agostino and Pearson normality test. * 0.05 
> P > 0.01, **** P < 0.0001. Bars are 95% CI. 
Dispersion of data in 680 mM ethanol was very likely due to the severe toxic effect of the alcohol 
onto slices that, differently from the two other experimental conditions in the study, displayed 
obvious morphological signs of tissue sufferance such as fragmentation, disaggregation, 
vacuolization, etc. It is worth noting that in vitro experiments onto cultured primary cerebellar 
granule cells demonstrated that 25 mM ethanol was already inducing death, but alcohol was 
generally used at much higher concentration (87–200 mM) to reach better statistical significance 
[44,45]. Thus, the concentration of ethanol in our PP control media is within the range of these in vitro 
experiments and compatible with that in organotypically cultured cortical neurons [46]. Yet our 
experiments show that 34 and 68 mM ethanol produced statistically significant increases in NOND, 
whereas there were no differences in the mean density of dead cells at 0 and 170 mM ethanol (mean 
± 95% CI: 17.56 ±1 7.73 (no ethanol), 23.47 ± 8.76 (170 mM ethanol), adjusted P value = 0.0815). We 
have also done a linear regression analysis to model the relationship between ethanol concentration 
in medium and cell death and found that the two variables showed a very high goodness of fit (R2= 
0.9386, Figure 3). The Pearson’s correlation coefficient was r = 0.9688. 
 
Figure 3. Linear regression curve of the density of dead cells related to different ethanol 
concentrations in culture media. Dead cells were stained with propidium iodide and results are 
expressed as means of dead cells/area. The curve demonstrates a positive correlation between the 
concentration of ethanol in medium and the density of dead cells. Slope was significantly non-zero: F 
= 30.55, P value = 0.0312. Equation: Y (dead cells/mm2) = 0.09141 × (ethanol concentration) + 11.15. Bars 
indicate 95% CI. 
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Based on these observations, we hold those experiments with PPs in which control- and PPs-
supplemented media contained 170 mM ethanol allowed us to monitor NOND appropriately and 
not ethanol-induced death. 
2.2. Effects of PPs onto NOND and Ethanol-Induced Cell Death 
Figure 1 shows, as an example, the results of incubating the organotypic cultures in the presence 
of 50 μM resveratrol (Figure 1B) or 50 μM (+)-catechin (Figure 1C). 
We have statistically tested the effects of PPs onto cerebellar NOND using two-tailed Mann–
Whitney tests (Figure 4–5). Statistics demonstrated that all PPs, except Mv-3OG (Figure 5G–H), were 
capable to reduce the density of dead cells in cerebellar cultures, with high significance. 
We also observed that all PPs were as well effective in reducing ethanol-induced cell death (F = 
15.11, P value < 0.0001) after Kruskal–Wallis test and Dunn’s multiple comparison test (P values for 
all comparisons against 680 mM ethanol as a control < 0.0001). Specifically, the mean density of dead 
cells per mm2 dropped from 78.11 (680 mM ethanol) to 16.20 (Pn-3OG), 13.59 (resveratrol), 10.53 (Q-
3OG), 9.41 (Mv-3OG) 9.15 (Cat), 3.30 (polydatin), and 1.25 (taxifolin). 
2.3. Comparison of the Effectiveness of PPs in Counteracting NOND 
As we have related the effects of each PP against its own ethanolic (Figure 4A–C, E–H) or 
aqueous (Figure 4D) control, our experimental setup did not allow for correctly performing multiple 
comparison tests to make statistical inferences about the existence of possible differences in 
neuroprotective activities among the molecules used in this study. Nonetheless, we have calculated 
the ratios of the density of dead cells in controls and in the presence of each PPs (Figure 5A–C, E–H) 
and, thus, the per cent reduction of cell death for each molecule (Table 1). It is noteworthy that among 
the PPs here studied, the stilbenes (resveratrol and polydatin) appeared to be less effective in 
reducing cell death in comparison to Cat (a flavan-3-ol), Q-3OG (a flavonol), (+)-taxifolin (a 
flavanonol), and Pn-3OG (an anthocyanin). These four molecules, in fact, displayed very close 
percentages of reduction of cell death (69–72%) that were by far higher than those calculated for the 
stilbenes (51–60%). A remarkable observation was that, albeit in a statistically not significant way, 
aqueous Mv-3OG only reduced the density of death cells to 40% and even increased it to 127% in 
ethanolic solution. 
Table 1. Percentages of reduction of the density of dead cells in controls (a) and after incubation in 
PPs (b) containing media. 
PPs 
Density of dead cells  
(PI+ cells/mm2) 
Ratio (b/a) 
control (a) PP (b) (c) 
Pn-3OG 57.43 16.2 0.28 
(+)-Catechin 31.32 9.15 0.29 
Taxifolin 4.128 1.249 0.30 
Q-3OG 34.04 10.53 0.31 
Resveratrol 34.04 13.59 0.40 
Polydatin 6.78 3.298 0.49 
Mv-3OG 
(Water) 
17.56 9.41 0.54 
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Figure 4. Descriptive exploratory statistics of the effect of different polyphenols (A = resveratrol; B = 
polydatin; C = Mv-3OG (malvidin 3-O-glucoside); D = aqueous medium-dissolved Mv-3OG; E =Pn-
3OG (peonidin 3-O-glucoside); F = Q-3OG (quercetin 3-O-glucoside); G = (+)-catechin; H = taxifolin) 
on cerebellar naturally occurring neuronal death (NOND). Dead cells were stained with propidium 
iodide and results are expressed as means of dead cells/area with 95% CI. Scatter graphs show the 
dispersion and variability of data. Abbreviations: CTRL = control medium containing 170 mM 
ethanol; CTRL (w) = control medium (aqueous). 
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Figure 5. Inferential statistics of the effects of different polyphenols (A = resveratrol; B = polydatin; C 
= Mv-3OG (malvidin 3-O-glucoside); D = aqueous medium-dissolved Mv-3OG; E =Pn-3OG (peonidin 
3-O-glucoside); F = Q-3OG (quercetin 3-O-glucoside); G = (+)-catechin; H = taxifolin) on cerebellar 
naturally occurring neuronal death (NOND). Dead cells were stained with propidium iodide and 
results are expressed as means of dead cells/area. The two-tailed Mann-Whitney test was applied, as 
data did not pass the D’Agostino and Pearson normality test. *** 0.0001 > P > 0.001, **** P < 0.0001. 
Bars are 95% CI. All PPs except Mv-3OG (C-D) reduced NOND in cerebellar slices. Abbreviations: 
CTRL = control medium containing 170 mM ethanol; CTRL (w) = control medium (aqueous). 
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3. Discussion 
In this study, we have analyzed the neuroprotective effects of seven different PPs among those 
known to be present at higher concentration in grapevine. 
Cell death in the postnatal cerebellum is a well-known physiological neurodevelopmental event 
mainly affecting the cerebellar granule cells that are the largest population of neurons in central 
nervous system (CNS). Being they so numerous, NOND of the granules is a massive phenomenon, 
and occurs in a quite restricted and tightly regulated temporal window [47]. Therefore, the use of 
postnatal cerebellar cortex organotypic cultures offers an adequate tool to study the neuroprotective 
potential of PPs in a controlled experimental setup [42]. 
Using this approach, we have demonstrated that all PPs studied here, except Mv-3OG, were 
capable to reduce NOND with statistical significance. We have also proved that all molecules without 
exceptions were also effective in counteracting the neurotoxic effects of 680 mM ethanol, a very high 
concentration in relation to studies on the toxic effects of alcohol. 
We will first discuss our results in relation to the suitability of the ex vivo approach to investigate 
grapevine PPs neuroprotection, then we will briefly consider the PPs’ chemical structure and 
antioxidant activities and finally take into consideration the biological relevance of our findings. 
3.1. Suitability of the Ex Vivo Approach to Study the Neuroprotective Effects of Grapevine PPs 
As summarized in the Introduction, preclinical works aiming to characterize the biological and 
protective activity of PPs in the frame of neurodegeneration/inflammation display several limitations 
to the point that there is a strong debate onto their real translational relevance. We here used an ex 
vivo method to get rid of some of these limitations. Yet the use of organotypic cultures is not free of 
problems and does not represent a situation without controversies. We are aware of the shortcomings 
of our approach that paves the way for future better-focused pharmacological studies in vivo. Still, 
we believe it useful to discuss here the main problems related to the (generally) scarce bioavailability 
of PPs after in vivo administration. Taking resveratrol (and the stilbenes in more general terms) as 
the paradigmatic PP, its quantity in red wines is usually around 0.6 mg/L [21] but stilbenes can be up 
to 35 mg/L in certain Piedmont’s red wines and autochthonous Uvalino, in particular, contains up to 
100 mg/L of resveratrol [48,49]. These figures correspond to concentrations of 2.6, 135, and 438 μM, 
respectively. Indeed, data are very dissimilar between studies and substantial differences exist in the 
reported concentrations of the several PPs that may be present in wines. It is thus remarkable that 
those of most PPs here studied (other than resveratrol) range in wines from 45 to above 750 μM 
[50,51]. To this, one must add that different wines have different profiles of PPs deriving from grape 
seeds, skins, and pulps [52]. However, one can reasonably conclude that in wine the molar contents 
of many of the PPs that we have studied, except for resveratrol but not in the autochthonous 
Piedmont Uvalino, are above those used ex vivo in our study. 
Yet, the real issue is the bioavailability of PPs and, primarily, the brain concentration that they 
may reach in vivo. Indeed, Tomé-Carneiro et al. [43], in reviewing preclinical and clinical studies on 
resveratrol, evidenced that the former often used concentrations up to 200 μM but that resveratrol, 
quercetin, and catechin and their metabolites were scant in both plasma and urine (max 2 μM). 
Therefore, from these (and other) considerations they concluded that most studies in vitro were 
irrelevant. 
Comparing our figures with those obtained from other preclinical surveys is not easy principally 
because, in most cases, results are expressed as the PP quantity in relation to brain weight, a very low 
quantity indeed, in the order of ng or even pg/mg of nervous tissue [53]. A more rigorous comparison 
takes into consideration the PPs concentration in the cerebrospinal fluid (CSF), which bathes the brain 
in vivo similarly to medium in our cultures. No resveratrol was detected in CSF after intravenous 
infusion in rat, but, after nasal delivery in chitosan-coated lipid microparticles, resveratrol reached a 
Cmax after 60 min of 9.7 ± 1.9 μg/mL [54], corresponding to 34–51 μM. 
Data onto the CSF content of PPs are scarce, but this paper strongly indicates that by choosing 
an appropriate pharmacological preparation as well as an efficient route of administration it is 
possible to achieve brain concentrations of resveratrol (and other PPs) comparable with those here 
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used ex vivo. This is an important result supporting the relevance ex vivo approaches to study PPs 
neuroprotection. 
3.2. The Relationship Between PPs Chemical Structure and Neuroprotective Effects 
The increasing interest in PPs extracted from vegetal matrix in relation to neuroprotection is 
primarily due to their widely established antioxidant capacity (AOC) that, following several different 
cellular mechanisms and pathways, may be beneficial to neurons [6,9]. In turn, AOC depends on the 
chemical structure of individual PPs. In addition, the molecular composition influences the 
bioavailability of PPs, as different aglycones display distinct efficiencies in cellular 
transport/absorption [55]. In vivo, bioavailability refers to the fraction of a drug/molecule that, after 
absorption, reaches unchanged the systemic circulation. When dealing with CNS, drugs/molecules 
must be able to also cross the BBB for reaching the nervous tissue and thence exert their biological 
activities [56]. In a system ex vivo, BBB is not an issue, yet PPs need to be able to cross cell membranes 
to reach intracellular compartments and have some sort of efficacy. Other issues that are irrelevant 
to the present discussion, as we have at the moment tested each PP separately, is the possible synergy 
or antagonism among different families of PPs that are present in grapevine extracts [57] as well as 
the degree of polymerization of certain natural compounds, such as proanthocyanidins and 
copigments [58]. 
Among the PPs studied, we have here observed that the flavonoids were more effective than the 
stilbenes in protecting cells from death, except for Mv-3OG (see below). 
Pn-3OG (anthocyanin) and Q-3OG (flavonol), both glucosides and di-substituted (Figure 6), 
showed a very high and statistically significant capacity to reduce NOND, of 72% and 69% respect to 
the corresponding control, and were among the most effective PPs in this study. We have here used 
these two PPs in glucoside form for three reasons. First, previous studies have reported that flavonoid 
glucosides can be absorbed as such without the need to be hydrolyzed to an aglycone [55]. Second, 
glucosides showed significantly higher transport efficiency than galactosides [55]. Third, they very 
likely enter the BBB as such, beside as glucuronide form, as demonstrated for anthocyanins [6]. Our 
results indicate that nor the glycosylation of the C ring of a di-substituted flavonoid form or its 
methylation (in 3′ of the B ring like in Pn-3OG respect to Q-3OG) negatively influenced the capability 
to reduce NOND. The anthocyanin Pn-3OG appeared to be the most effective in limiting not only 
NOND but also to counteract the adverse effects of high concentrations of ethanol in media. 
Therefore, it might be postulated that the B ring level of hydroxylation not alone but together with 
the total unsaturation of the C ring, typical of the anthocyanin molecules [59,60], are the key elements 
for explaining the capacity of Pn-3OG to drastically limit neuronal cell death in our ex vivo paradigm. 
The flavonoids (+)-catechin and (+)-taxifolin are also among the PPs demonstrating the highest 
efficacy in reducing NOND. They are aglycones, but, like Pn-3OG and Q-3OG, di-hydroxylated, in 
the B ring (Figure 6). 
(+)-taxifolin (flavanonol) and Q-3OG displayed similar capacities to limit NOND, 69 and 70% 
respectively. The two molecules share identical hydroxylation of the B ring but two different 
unsaturations in C (Figure 6). In addition, (+)-catechin, (+)-taxifolin, and Q-3OG have an ortho-
hydroxyl in B, which is usually the initial target of antioxidants [61]. 
The null effect exerted by Mv-3OG on NOND but not on ethanol-induced cell-death could be 
ascribed to several factors, among which is the tendency of tri-hydroxylated anthocyanins to degrade 
in vitro more rapidly than mono and di-hydroxylated anthocyanins [29] and the limited efficiency in 
cell transport of glucosides respect to galactosides [55]. 
Thus, there may be several chemical features of the different flavonoids that, in theory, 
contribute to the neuroprotective effects observed in this study, but additional observations will be 
required to substantiate a significant correlation with some or all of them. 
The two stilbenes, resveratrol, and its glycoside (polydatin, also called piceid) were undoubtedly 
less effective in counteracting NOND. Yet, resveratrol capacity to limit cell death was higher respect 
to that of the corresponding glucoside. One of the main antioxidant mechanisms of resveratrol is 
based on the presence of two -OH groups in the ring B [62]. Besides, in the comparison vs quercetin, 
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quercetin has a further reactive -OH in position 3′, which is absent in resveratrol. Thus, the resveratrol 
chemical structure may justify a lower AOC respect to that of other PPs, particularly some of the 
flavonoids that we have tested here. 
3.3. Clues for In Vivo Neuroprotection 
We have here tested PPs in a controlled environment ex vivo. In such a setup, advantages mainly 
derive from the possibility to manipulate carefully and specifically the system according to the 
experimenter’s need, whereas disadvantages derive largely from the lack of information about 
bioavailability, metabolism and capability of crossing the BBB, i.e., the group of data that can be 
gathered only in vivo. Yet our approach permitted to provide an empirical demonstration that all PPs 
studied here were capable to cross cell membranes and to interfere with NOND. In addition, a great 
advantage in the specific use of postnatal cerebellar cultures is that cell death in this system is chiefly 
governed by the intracellular levels of caspase-3 (CASP3), one of the most important executioner 
caspases in apoptosis [47]. Although it is difficult to make direct comparisons due to the extreme 
variability of approaches, still one observes that all PPs that we have studied have been demonstrated 
to interact with CASP3 in vitro and/or in vivo not only in neurons but also in neuronal-like cells 
(Table 2). Remarkably, it should also be added that most of these molecules appeared to inhibit the 
activity of CASP3 after Aβ toxicity, a hallmark of AD [63]. 
Table 2. Experimental studies demonstrating an inhibition of caspase-3 (CASP3)-mediated apoptosis 
after treatment with plant PPs. Abbreviations: Aβ = amyloid-beta; APP = amyloid precursor protein; 
IRI = ischemia/reperfusion injury; OGD = oxygen/glucose deprivation; LPS = lipopolysaccharide; N/A 




Organ/tissue/cell/Species Death inductor  Ref 
Resveratrol 
In vitro 
PC12 cells/Rat Aβ [64] 
Primary cortical neurons/Rat Aβ [65] 
661W photoreceptor cells/Mouse  Blue light [66] 
SH-SY5Y cells/human  Ethanol [67] 
In vivo Brain/Rat Ethanol  [67] 
Polydatin 
In vitro PC12 cells/Rat Aβ [64] 
In vivo 
Primary cortical neurons/rat Aβ [65] 




Hippocampal HT22 cells/Mouse Aβ [69] 





APP/PS1 mouse model of AD  N/A [69] 
Brain/Rat LPS [72] 
Hippocampus/Rat Ethanol [73] 
Peonidin In vitro RGC-5/Mouse Tunicamycin [70] 
Malvidin In vitro 661W photoreceptor cells/mouse  Blue light [66] 
Quercetin 
In vitro 





Brain/Rat IRI [75] 
Hippocampus/Mouse IRI [76] 
Brain/Rat IRI [77] 
Epicatechin 
In vivo Brain/Rat LPS [78] 
In vitro Auditory cells Cisplatin [79] 
Epigallocatechin 
In vitro SH-SY5Y cells/human  Aβ [80] 




Taxifolin In vitro PC12 cells/Rat Proteasome inhibition [81] 
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4. Materials and Methods 
4.1. PPs 
We tested seven different PPs belonging to five main groups present in wine and grapevine 
extracts (Figure 6): two anthocyanins, peonidin 3-O-glucoside (Pn-3OG) and malvidin 3-O-glucoside 
(Mv-3OG), two stilbenes, resveratrol (Res) and resveratrol-3-O-β-D-glucopyranoside (polydatin), one 
flavonol [quercetin 3-O-glucoside (Q-3OG), purchased as quercetin 3-O-glucopyranoside], one 
flavan-3-ol, (+)-catechin (Cat) and one flavanonol (2R,3R)-dihydroquercetin [(+)-taxifolin]. All PPs 
were purchased from Extrasynthèses (Genay, France). Stock solutions (5 mM) were prepared in 
absolute ethanol and/or water (for Mv-3OG only). Given the pilot nature of this work and the 
heterogeneity of results arising from the different wine PPs extraction procedures (see Introduction), 
we decided not to devise experiments using mixtures of PPs as these mix should more properly been 
produced once their (relative) concentrations in the territorial wines of interest will be fully 
established. 
 
Figure 6. Chemical formulas of the PPs used to study neuroprotection in postnatal cerebellum. 
4.2. Animals 
In this study, we used twenty-five 7-day-old mice. All animal procedures obtained authorization 
by Italian Ministry of Health and the Bioethics Committee of the University of Turin and were carried 
out according to the guidelines and recommendations of the European Union (Directive 2010/63/UE) 
as implemented by current Italian regulations on animal welfare (DL n. 26-04/03/2014). We kept the 
number of mice to the minimum necessary for statistical significance and we made all efforts to 
minimize animal suffering during sacrifice. We wanted to gather new information about the 
biological function(s) of grapevine PPs in a more complex system than primary neuronal cultures/cell 
lines, where interactions between different cell types are lost. Therefore, mice were employed; yet the 
use of an approach ex vivo permitted a reduction in their number according to the 3Rs principles. 
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4.3. Preparation of Cerebellar Cultures 
Mice were euthanized with an overdose of intraperitoneal sodium pentobarbital. The brain was 
quickly removed and placed in ice cooled Gey’s solution (Sigma Chemicals, St. Louis, MO) 
supplemented with glucose and antioxidants (for 500 mL: 50% glucose 4.8 mL, ascorbic acid 0.05 g, 
sodium pyruvate 0.1 g). The cerebellum was then isolated and immediately sectioned in 350 μm 
parasagittal slices with a McIlwain tissue chopper (Brinkmann Instruments, Westbury, NY), while 
submerged in a drop of cooled Gey’s solution. Three cerebellar slices were plated onto Millicell-CM 
inserts (Millipore, Billerica, MA). Each insert was subsequently placed inside a 35 mm Petri dish 
containing 1 mL of culture medium. Medium composition was 50% Eagle basal medium (BME, Sigma 
Chemicals, Merck, Darmstadt, Germany), 25% horse serum (Gibco®, Life Technologies™, Carlsbad, 
CA), 25% Hanks balanced salt solution (HBSS, Sigma Chemicals, Merck, Darmstadt, Germany), 0.5% 
glucose, 0.5% 200 mM L-glutamine, and 1% antibiotic/antimycotic solution. Cultures were incubated 
at 34° C in 5% CO2 for 4 days in vitro (DIV) before being treated with PPs. 
4.4. Preparation of PPs-Containing Media, Incubation of Cultures with PPs and Staining of Dead Cells 
Except for Mv-3OG that could also be directly dissolved in water, all other PPs were not soluble 
in water and were added to the culture medium from ethanolic stock solutions. Culture media 
containing 50 μM of each of the PPs were prepared by dissolving 10 μL 100% ethanol stock solutions 
in 1 mL medium. The same volume of ethanol was added to control media. In the case of Mv-3OG 
we prepared culture media both from ethanolic and aqueous stocks. 
As alcohol is known to be toxic to neurons, we devised an ad hoc series of experiments to 
ascertain the effects of ethanol onto neuronal survival at the concentration necessary to prepare the 
PPs containing media (170 mM–corresponding to 10 μL ethanol/1 mL medium). In these experiments, 
we also incubated some cerebellar cultures in 340 mM or 680 mM ethanol (i.e., 20 or 40 μL ethanol/1 
mL medium). 
At DIV 5 cerebellar cultures were subdivided in five groups and incubated into: i. Fresh plain 
medium (control for ethanol toxicity at 170 mM); ii. medium with 170 mM ethanol (control medium 
for PPs experiments); iii. Medium with 340 mM ethanol; iv. medium with 680 mM ethanol; and v. 
Medium containing 50 μM of each PP dissolved in ethanol (at a 170 mM final concentration). After 
24 h, cultures were incubated for 10 min in medium containing 1.5 mM propidium iodide (PI) to 
visualize the dead cells. We decided to employ PI, a general marker of cell death rather than focusing 
onto a more specific assay because there are severe concerns about the specificity of action of several 
plant PPs onto animal cells [3]. In addition, the number of cellular mechanisms that have been put 
into play for explaining the numerous purported actions of resveratrol and other vegetal PPs is so 
high that virtually all the major cell pathways appeared to be involved [82], at times with opposite 
effects [20]. In addition, PI is widely used to stain dead cells as it is extruded from live cells with an 
intact membrane irrespective of the mechanism and type of death [83] and PI-based experiments thus 
offered prompt and, very importantly, comparable readouts of the effect of each PP onto NOND, 
independently from its mechanism(s) of action. 
After three washes in plain medium, cultures were fixed for 60 min in 4% paraformaldehyde 
dissolved in 0.1 M phosphate-buffered saline (PBS) pH 7.4–7.6. They were then washed in PBS (2 × 
10 min) and double-distilled water (2 × 5 min) and finally mounted in fluorescence-free medium 
(Vectashield® Antifade Mounting Medium, Vector Laboratories, Burlingame, CA). Slices were then 
photographed using a Leica DM6000 wide-field fluorescence microscope (Leica Microsystems, 
Wetzlar, Germany) with a 20 × lens. For each slice, three randomly selected microscope fields (0.3084 
mm2) were photographed at a resolution of 1392 × 1040 pixels and PI-stained nuclei were counted 
with the “Count Particles” function of the ImageJ software (NIH, Bethesda, MD, USA) in an interval 
of area size between 12.56 and 78.50 μm2 (corresponding to a particle diameter of 4–10 μm). Results 
were expressed as the number of PI-stained cells (nuclei)/mm2, i.e., density of PI-stained cells (nuclei). 
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4.5. Statistical Analysis 
GraphPadPrism®7 (GraphPadSoftware, San Diego, CA, USA) was used for statistical analyses. 
These included I. Linear regression analysis and Pearson’s correlation test on the effects of different 
ethanol concentrations on the density of dead cells in cultures. II. D’Agostino and Pearson omnibus 
normality test to check for normally distributed data. III. Unpaired two-tailed Mann–Whitney test to 
make comparisons between two groups (control and PP-treated cultures). 
Multiple comparisons for control experiments with different ethanol concentrations were made 
using the non-parametric Kruskal–Wallis test followed by Dunn’s multiple comparisons test. 
5. Conclusions 
In conclusion, we here demonstrate the usefulness of the ex vivo approach to study the 
neuroprotective potential of grapefruit PPs. Further studies will be required to confirm the relevance 
of our experiments in vivo considering the well-known problems regarding the bioavailability of 
these molecules following conventional pharmacological administration. 
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